Author + information
- Received February 14, 2020
- Revision received March 27, 2020
- Accepted March 31, 2020
- Published online July 20, 2020.
- Estêvão Carvalho de Campos Martins, MDa,∗ (, )
- Fernando Luiz de Melo Bernardi, MDb,
- Orlando Teixeira Maia Junior, MDc,
- Antonio Micari, MD, PhDd,
- Leo Nelson Hopkins, MDe,f,g,h,
- Alberto Cremonesi, MDd and
- Fausto Castriota, MDd
- aHospital da Força Aérea do Galeão, Interventional Cardiology Unit, Rio de Janeiro, Brazil
- bHospital São Francisco, Interventional Cardiology Unit, São Camilo, Concórdia, Brazil
- cHospital da Força Aérea do Galeão, Neurosurgery and Endovascular Neurosurgery Unit, Rio de Janeiro, Brazil
- dCardiovascular Unit, Humanitas Gavazzeni Hospital, Bergamo, Italy
- eDepartment of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York
- fCanon Stroke and Vascular Research Center, University at Buffalo, Buffalo, New York
- gDepartment of Neurosurgery, Gates Vascular Institute at Kaleida Health, Buffalo, New York
- hJacobs Institute, Buffalo, New York
- ↵∗Address for correspondence:
Dr. Estêvão Carvalho de Campos Martins, Hospital de Força Aérea do Galeão, Interventional Cardiology Unit, Estrada do Galeão 4101, Ilha do Governador, Rio de Janeiro, Brazil.
• Properly trained interventional cardiologists can be an asset given the high demand for MT.
• Interventional cardiologists must be familiar with technical aspects of MT and the AIS worklfow.
• More cooperation among specialties will be key for reducing the societal burden of stroke.
Acute ischemic stroke is among the leading causes of mortality and disability worldwide. Since 2015, as was the case for primary percutaneous coronary intervention for acute myocardial infarction, catheter-based reperfusion via mechanical thrombectomy (MT) has become the gold-standard treatment for acute ischemic stroke caused by large-vessel occlusion. Despite that, only a fraction of the world’s population currently would be able to undergo MT in time, mostly because of the scarcity of 24/7 coverage by neurointerventionalists to deal with this enormous burden. Interventional cardiologists have thus been considered a logical option to aid in combating this vast demand to diminish the burden of acute ischemic stroke. However, despite some seemingly evident similarities between primary percutaneous coronary intervention and MT, for interventional cardiologists to enter this new field, they must be well trained and fully aware of all the clinical, technical, and environmental differences between these two scenarios. The main objective of this state-of-the-art paper is to serve as an introductory and comprehensive guide to familiarize the interventional cardiology community with the most critical technical aspects of MT.
- acute ischemic stroke
- interventional cardiologist
- large vessel occlusion
- mechanical thrombectomy
- primary percutaneous coronary intervention
Dr. Martins contributes to and receives grants from GE Healthcare for lecturing on mechanical thrombectomy for the SPREAD MT course in mechanical thrombectomy for interventional cardiologists. Dr. Hopkins has received grant and research support from Canon Medical Systems; has financial interests or stock in Boston Scientific, Cerebrotech, Endostream, Endomation, Silk Road, Ostial Corporation, Imperative Care, StimSox, Photolitec, ValenTx, Ellipse, Axtria, NextPlain, and Ocular; holds a board/trustee/officer position in Imperative Care; and has a financial interest and holds a board position in Vastrax, a clinical trials management company. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Interventions author instructions page.
- Received February 14, 2020.
- Revision received March 27, 2020.
- Accepted March 31, 2020.
- 2020 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.